Loading...
NPI 1720084999 · Gallup, NM · Critical Access Hospital
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Rehoboth Mckinley Christian Health Care Services, Inc. is a critical access hospital provider located in Gallup, New Mexico. This profile covers 0 Medicare and 263 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Rehoboth Mckinley Christian Health Care Services, Inc. |
| Address | 1901 Redrock Drive |
| City | Gallup |
| State | NM |
| ZIP | 87301 |
| Taxonomy | Critical Access Hospital |
| NPI Enumerated | June 22, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $31.9M |
| Medicare | $0 |
This provider is effectively single-payer in our data: there is no Medicare billing on file for REHOBOTH MCKINLEY CHRISTIAN HEALTH CARE SERVICES, INC. (Medicare revenue: none below), while total Medicaid revenue is $31.9M, indicating Medicaid is the primary revenue source captured in claims. Analysts should treat this profile as Medicaid-dominant when assessing network value or contracting leverage.
Revenue concentration is high within a small group of emergency department evaluation-and-management codes: the precomputed top three Medicaid codes (99284, 99283, 99285) account for 54.1% of total Medicaid revenue. Those three codes are reported as 99284: $5.7M (21.9%), 99283: $5M (19.1%), and 99285: $3.4M (13.1%), so most Medicaid dollars are driven by ED visits at moderate, low, and high complexity levels.
The code mix points to an emergency-department–centric operating model consistent with the provider’s Critical Access Hospital taxonomy: the largest revenue drivers are ED E/M codes (99282–99285) and the dataset also shows routine use of hospital observation (G0378) and high-volume IV/infusion administration codes (for example, 96361: $778.9K, 96365: $698.6K, 96375: $681.4K). Together these suggest the facility provides front-line emergency care with substantial short-stay observation and frequent IV therapies rather than large elective inpatient services.
Ancillary services that support an ED/acute-care footprint are also material. Imaging and lab codes such as 74177: $1.4M (5.2%), 70450: $663.7K (2.5%), and 87635: $732.6K (2.8%) appear regularly in the top code list, indicating on-site CT and molecular testing capacity; 87635 is specifically flagged as notably above typical state volume (ranks #6 of 113 providers in-state, 96th percentile), which may reflect unusually high local SARS–CoV–2 testing activity or centralized testing for the community.
Competitive standing across the state is mixed: the three highest Medicaid revenue codes for this provider are described as typical or unremarkable in state volume (99284 ranks #24 of 76, 69th percentile; 99283 ranks #19 of 84, 78th percentile; 99285 ranks #25 of 71, 66th percentile), so the provider is not a statewide dominant ED billing outlier but is a consistent, above-median contributor for several ED codes. By contrast, certain lab and infusion codes rank in the higher percentiles (for example, 96361 ranks #6 of 40, 87th percentile; 0241U ranks #5 of 29, 86th percentile) yet are still described with the plain-English label “typical, unremarkable volume for this code,” suggesting pockets of relatively high utilization within an otherwise typical state footprint.
Tenure data show the NPI was enumerated on 2005-06-22 (~21 years ago), indicating a long-established presence in the market; this longevity supports the interpretation that current billing patterns reflect sustained service lines rather than a short-term operational anomaly.
For payer and provider analysts, the concentration of Medicaid dollars in ED E/M codes (54.1% across the top three) and the absence of Medicare claims imply negotiations or value-based arrangements should focus on emergency care workflows, observation-level services (G0378), and high-volume ancillary lines like CT, respiratory pathogen testing, and IV drug/fluids administration. Given the revenue concentration, changes to ED utilization or Medicaid reimbursement could materially affect the provider’s financial picture, so contract design and utilization-management strategies should explicitly account for these service lines.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
263 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 22,590 | $250 | $5.7M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 27,880 | $180 | $5M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 10,840 | $320 | $3.4M |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 3,460 | $390 | $1.4M |
| G0378 | Hospital observation service, per hour | 2,160 | $400 | $860.2K |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 12,980 | $60 | $778.9K |
| 0241U | N/A | 4,680 | $160 | $739.6K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 13,570 | $50 | $732.6K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 5,970 | $120 | $698.6K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 11,170 | $60 | $681.4K |
Showing 1–10 of 263
How this provider's Medicaid billing volume and revenue compare to other New Mexico providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Mexico median
263 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 24 | 80 | 12,050 | $160 | $3.9M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 25 | 70 | 6,920 | $210 | $3.5M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 32 | 40 | 3,670 | $80 | $3.2M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 19 | 80 | 10,650 | $130 | $2.4M |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 22 | 60 | 3,070 | $210 | $1.4M |
| G0378 | Hospital observation service, per hour | 13 | 40 | 1,000 | $400 | $1M |
| 87636 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, and influenza B using a multiplex amplified nucleic… | 20 | 30 | 3,760 | $120 | $900.7K |
| 70450 | The provider performed computed tomography, or CT scanning, of the head or brain, without contrast. He performs the procedure to diagnose any brain or intracranial abnormalities. | 26 | 60 | 2,820 | $110 | $799.5K |
| 76811 | The provider performs an ultrasound study using a transabdominal approach to examine the fetus and mother, along with additional examination of the fetal anatomy, such as the heart rate, amniotic… | 11 | 20 | 1,230 | $230 | $753.6K |
| 93005 | The provider records the electrical conduction of the heart to examine any abnormality in its functioning, based on signals from at least 12 leads, wires that connect the recording device to… | 15 | 50 | 7,300 | $60 | $737.6K |
Showing 1–10 of 263
Other providers in the same ZIP code as Rehoboth Mckinley Christian Health Care Services, Inc., ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.